About the Forum:

In 2015 we have decided to bring forward our 3rd Annual MedTech & Digital Health Forum for Technology & Healthcare Innovation and hold it in Basel before the 15th Annual Biotech in Europe Forum for Global Partnering & Investment, which is being held on 29th-30th September 2015 for the second time at the Congress Center Basel, Switzerland.


The programme is designed to highlight the latest industry developments and  showcase emerging and innovative technology companies seeking finance and partnerships. The delegates are comprised of Healthcare, MedTech, Healthcare IT, and Digital Health companies as well as consultants, bankers and corporate & financial investors. We expect over 200 delegates and 25 presenting companies plus demos.

!!! Detailed Agenda is live & One-2-One online meeting system is live for sending messages and booking meetings !!!
Plenary Discussion Panels on:
• Digital Health
• Healthcare IT
• MedTech and Device BD and M&A
• Investment

The Digital Health panel will concentrate on the consumer health and tracking personal health, whereas healthcare IT Panel will cover Big Data for Pharma, electronic health records technology and admin tools.
Confirmed Speakers Include:

Keynote Speakers: 
  • David Cassak, Managing Partner, Innovation in Medtech, LLC
  • Stephen Levin, Managing Partner, Innovation in Medtech, LLC

Speakers & Chairs: 
  • Adelaide Cracco, Investment Manager, European Investment Fund
  • André Mercanzini, Founder and CTO, Aleva Neurotherapeutics SA
  • Anne Portwich, Partner, Life Sciences Partners
  • Bart de Witte, Government & Healthcare Leader CEE, IBM
  • Beat Lechmann, Director R&D EMEA, Mitek Sports Medicine, DePuy Synthes
  • Beat Merz, Managing Director, Rockport Venture Partners
  • Bill Blair, Head of Business Creation, Edinburgh BioQuarter
  • Christian Marcazzo, VP of Commercial EMEA, Zephyr Health, Inc.
  • Christoph Kausch, Chief Executive Officer, MedTech Innovation Partners AG
  • David G. Peoples, Executive Director, Healthcare Investment Banking, J.P. Morgan
  • Francois Martelet, Group CEO, NetScientific PLC
  • Frank Bulens, Partner Health-tech Investment Practice, Capricorn Venture Partners NV
  • Gary Brothers, Senior Corporate Development Director, Medtronic, Inc.
  • Gauti Reynisson, Co-Founder and CEO, Mint Solutions BV
  • Holger Reithinger, General Partner, Forbion Capital Partners
  • Janne Huhtala, CEO, Nextism
  • Jennifer McKeever, Senior Analyst, Seroba Kernel Life Sciences Ltd.
  • John Mulcahy, Head of Global Business Franchise Medical Devices, Merck Serono
  • Josep Sanfeliu, General Partner, Ysios Capital Partners
  • Klaus Stoeckemann, Managing Partner, Peppermint Venture Partners GmbH
  • Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences
  • Laurent Gradidier, CEO, Xeltis AG
  • Marco Chiadò Piat, VP, Strategy, BD and New Growth Initiatives Cardiac Surgery Business Unit, Sorin
  • Maurizio PetitBon, General Partner, Kreos Capital
  • Markus Hosang, General Partner, BioMedPartners AG
  • Peter Crosby, President & CEO, Mainstay Medical Intl. PLC
  • Peter Ohnemus, President & CEO, dacadoo ag
  • Thierry Zylberberg, Director, Orange Healthcare
  • Ulrich Muehlner, Global Head Outcomes Technologies Incubator (NOVAE), Novartis Pharma AG
  • Wolfgang Rencken, CEO, Sphere Medical Holding PLC

Confirmed Presenting Companies Include:

  • Acarix AS
  • aeon scientific AG
  • Aleva Neurotherapeutics S.A.
  • dacadoo Health Score
  • Ethimedix SA
  • GILUPI GmbH
  • HeadSense Medical, Inc.
  • Implandata Ophthalmic Products GmbH
  • iSTAR Medical S.A.
  • Laxxon Medical Ltd.
  • Lightpoint Medical Ltd.
  • Mainstay Medical Intl. PLC
  • Mellon Medical B.V.
  • Mint Solutions Holland BV
  • MyoPowers Medical Technologies France SAS
  • NetScientific PLC
  • Novian Health, Inc.
  • Rapid Biosensor Systems Ltd. 
  • Sphere Medical Holding PLC
  • ViroGates A/S
  • Zephyr Health, Inc.
Click Here to view details of the 2014, 2nd Annual MedTech and Diagnostics Summit
Supported by:
Financial/Advisory/
Investors Attending:
Abingworth LLP
ACXIT Lifesciences GmbH 
Aravis SA
Bergmann zur Hausen & Cie.
BioMedPartners AG
Capricorn Venture Partners 
CD Venture GmbH
Cederberg GmbH 
Coulter Partners
Cukierman & Co. Life Sciences
Deutsche Bank AG
Eminent Venture Capital Corporation 
Eminent Venture Capital Corporation/TaiAn Technologies
Ernst & Young
Evidera 
Global Life Science Ventures
i-net innovation networks
Inbio Ventures
Inserm Transfert Initiative
IPF Partners
JP Morgan
JSB Partners LP
LifeCare Partners
LSP (Life Sciences Partners)
MedTech Innovation Partners AG
Medtronic, Inc.
Mercadyne Investments, LLC
Mint Solutions
Nextech Invest Ltd
Omega Funds 
Orange Healthcare
Peel Hunt LLP
Peppermint Venture Partners
Percipient Capital
Pier 88 Investment Partners 
Privateq Advisors AG
Remaco AG
RMI Partners
Rockport Venture Partners
Seroba Kernel Life Sciences
SFO Partners 
Siemens Technology Accelerator GmbH
Silicon Valley Bank 
Sirius Healthcare Partners
Societe Generale
Sorin Group Italia S.r.l.
Stratos Bio
TaiAn Technologies 
Thuja Capital B.V.
Ventac Partners 
Ventac Partners GmbH
VI Partners AG
Visium Asset UK LLP
Vogel BioC
Wellington Partners
XOventure GmbH
Ysios Capital Partners